FEATURE SELECTION APPLIED TO MICROBIOME FOR DRUG DISCOVERY - Archive ouverte HAL
Communication Dans Un Congrès Année : 2023

FEATURE SELECTION APPLIED TO MICROBIOME FOR DRUG DISCOVERY

Résumé

Inflammatory bowel disease (IBD) is a term that describes conditions characterized by chronic inflammation of the gastrointestinal (GI) tract caused by various factors: abnormal gut microbiota, immune response dysregulation, environmental changes and gene variants. There are two types of IBD: Crohn’s disease (CD) and ulcerative colitis (UC). Currently, there is no treatment for IBD, but it can be managed by using aminosalicylates, immunosuppressants or biologics.
Fichier principal
Vignette du fichier
Rojas-Velazquez_Hal.pdf (183.47 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Licence

Dates et versions

hal-04097608 , version 1 (15-05-2023)

Licence

Identifiants

  • HAL Id : hal-04097608 , version 1

Citer

David Rojas-Velazquez, Sarah Kidwai, Lara Cerezin, Luciënne de Vries, Kosta Besermenji, et al.. FEATURE SELECTION APPLIED TO MICROBIOME FOR DRUG DISCOVERY. CMBBE 2023 - 18th International Symposium on Computer Methods in Biomechanics and Biomedical Engineering (CMBBE 2023), May 2023, Paris, France. ⟨hal-04097608⟩
139 Consultations
37 Téléchargements

Partager

More